Overview
Pyogenic infection of the intervertebral disc (discitis) involves bacterial invasion leading to inflammation and potential structural damage within the disc. Effective management requires accurate diagnosis and targeted antibiotic therapy to achieve therapeutic drug concentrations within the disc.Diagnosis
Imaging Patterns: Vertebral marrow oedema patterns on MRI can aid differentiation:
- Pattern II (vertebral oedema adjacent to the intervertebral space but not sharply marginated or involving the entire vertebral body) is most common in discitis 2.
Recommended Tests: MRI with STIR sequences to evaluate bone marrow oedema patterns 2.
Clinical Correlation: Essential for confirming diagnosis, especially distinguishing between infectious and degenerative changes 2.Management
Antibiotics:
- Vancomycin: Intravenous infusion of 1 g every 12 hours achieves concentrations up to 31 times the minimum inhibitory concentration (MIC) 1.
- Cefepime: Intravenous infusion of 2 g every 12 hours achieves concentrations up to 4.2 times the MIC 1.
- Charge Effects: Positively charged antibiotics penetrate more effectively into intervertebral discs compared to negatively charged ones 3.
Dosage and Timing: Consider repeated dosing every 12 hours to maintain therapeutic levels within the disc 13.Special Populations
No Specific Guidance: The provided abstracts do not offer specific recommendations for pregnancy, pediatrics, elderly patients, or those with comorbidities 123.Key Recommendations
Utilize MRI with STIR sequences to identify characteristic vertebral marrow oedema patterns, particularly pattern II, for diagnosing discitis (Evidence: Moderate 2).
Administer vancomycin intravenously at 1 g every 12 hours to ensure therapeutic concentrations within the intervertebral disc (Evidence: Moderate 1).
Consider positively charged antibiotics like cefepime for enhanced penetration into the disc, administered intravenously at 2 g every 12 hours (Evidence: Moderate 13).References
1 Zhu Q, Gao X, Brown MD, Eismont F, Gu W. Transport of Vancomycin and Cefepime Into Human Intervertebral Discs: Quantitative Analyses. Spine 2019. link
2 Shrot S, Sayah A, Berkowitz F. Can the pattern of vertebral marrow oedema differentiate intervertebral disc infection from degenerative changes?. Clinical radiology 2017. link
3 Zhu Q, Gao X, Li N, Gu W, Eismont F, Brown MD. Kinetics of charged antibiotic penetration into human intervertebral discs: A numerical study. Journal of biomechanics 2016. link